Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Each pen contains a single-use dose and must be taken weekly ... It was launched in the US by the pharmaceutical company AstraZeneca under the brand name Byetta in 2005. It was later marketed in a ...

The Samsung Galaxy S25 Ultra S Pen no longer supports Bluetooth connectivity, removing features like Air Actions. Samsung says the change was made due to low user engagement and suggests using ...

a type 2 diabetes treatment made by AstraZeneca and sold under the brand name Byetta, or with a placebo. The trial was funded by Britain’s National Institute for Health and Care Research with ...

Samsung has removed Bluetooth functionality from the Galaxy S25 Ultra’s S Pen. Without Bluetooth, the S Pen does not support Air Actions and can no longer be used as a remote. The Galaxy S25 ...

The S Pen has been one of the standout features on Samsung flagships for many years. First integrated with the Note line, the S Pen is now a core part of the Galaxy S Ultra models, newer foldables ...

After the ceremony concluded, he did something unusual that made the crowd break into loud cheers: He threw the pens he used to sign the orders and directives into the crowd. President Trump's ...

A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easing its symtoms. The trial, published Feb. 4 in The Lancet ...

A landmark study involving over 2 million patients shows weight loss drugs like Ozempic, Wegovy, and Mounjaro double the risk of pancreatitis and cause increased incidents of nausea, arthritis, and ...